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Diagnosis: reactivated, disseminated histoplasmosis.
Histological examination of laryngeal biopsy specimens
showed the presence of budding yeast cells (Figures 1 and 2).
Based on this observation, laryngeal histoplasmosis with
underlying iatrogenic hypercortisolism, steroid-induced hyper-
tension, and diabetes mellitus was suspected. Histopathologi-
cal reexamination of the adrenal glands, which had been
removed in 1996, also raised suspicion of adrenal histoplasmo-
sis instead of the previously suspected culture-negative tuber-
culosis. The presence of Histoplasma capsulatum in both the
laryngeal and adrenal gland tissues was demonstrated by
broad-spectrum polymerase chain reaction (PCR) targeting
the fungal internal transcribed spacer (ITS) region, followed
by sequence homology analysis of the PCR product [1].
H. capsulatum genotyping using 4 targets of sufﬁcient intra-
species variability (arf, h-anti, ole, and tub1) [2, 3] provided
proof that reactivation, not reinfection, took place. Interesting-
ly, tests for speciﬁc antibodies remained negative twice, but
H. capsulatum antigen detection from a urine sample obtained
after 2 weeks of antifungal therapy was positive. After 6 weeks
of incubation, H. capsulatum was also cultivated from the pa-
tient’s urine (Figure 3).
Treatment with itraconazole was initiated according to the
current Infectious Diseases Society of America guidelines [4].
The hoarseness disappeared almost completely, but hospitali-
zation became necessary due to progressive asthenia. Cranial
computed tomography (CT) scan was not indicative of cere-
bral histoplasmosis, but CT scans of the chest and abdomen
suggested bilateral pulmonary involvement. The patient, who
always had sufﬁcient capacity of discernment, chose to discon-
tinue any treatment, including hydrocortisone substitution,
and died from hypocortisolism 2 months after the diagnosis
of disseminated histoplasmosis was made. The development of
diabetes mellitus and immunological changes as a result of ad-
vancing age may have contributed to the reemergence of the
pathogen 15 years after the initial manifestation.
Only <1% of individuals infected with H. capsulatum
develop symptomatic disease. The severity of symptoms
depends on the degree of exposure and the immune status of
Figure 2. Grocott–Gomori methenamine silver stain (magniﬁcation
×400) showing blastoconidia of H. capsulatum and the typical narrow-
necked budding (arrows).
Figure 1. Yellowish, edematous mucosal changes in the interarytenoid
region involving the posterior part of the vocal cords (arrows). Along with
Addison’s disease, mucous membrane lesions are a characteristic mani-
festation of H. capsulatum infection.
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the host, and can range anywhere from mild pulmonary affec-
tion to severe disseminated disease. Disseminated disease
mostly occurs in patients with impaired cell-mediated immu-
nity [5]. In this context, it is remarkable that invasive fungal
infections are not consistently recognized in patients treated
with immunosuppressants like corticosteroids and tumor ne-
crosis factor–α blockers [6, 7].
Disseminated histoplasmosis can affect every organ system.
Involvement of mucous membrane tissue in combination with
Addison’s disease due to the destruction of both adrenal
glands are particularly indicative of histoplasmosis compared
to other systemic mycoses. Reactivation of a silent focus can
occur decades after the initial exposure [6, 8].
H. capsulatum is highly prevalent in the central and south-
eastern parts of the United States as well as in Central and
South America and parts of Africa. However, our case shows
that, due to increasing international travel activity, infection
needs to be ruled out in a wide variety of clinical scenarios,
not only within endemic regions. In addition to traditional di-
agnostic techniques (histopathology, serology, and culture),
broad-spectrum PCR targeting the fungal ITS region is a valu-
able tool for the detection of this potentially fatal pathogen,
not least in settings where reliable histopathological identiﬁca-
tion may be difﬁcult to obtain.
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Figure 3. White to buff-brown mould form of H. capsulatum grown at
25°C on Sabouraud’s dextrose agar. Large numbers of infectious conidia
may be released by the mere lifting of the culture plate lid.
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